Loss of Histone Deacetylase 4 Causes Segregation Defects during Mitosis of p53-Deficient Human Tumor Cells

scientific article published on 21 July 2009

Loss of Histone Deacetylase 4 Causes Segregation Defects during Mitosis of p53-Deficient Human Tumor Cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1158/0008-5472.CAN-08-2796
P698PubMed publication ID19622775

P50authorRaffaele De FrancescoQ42659695
Bruno CadotQ57165983
P2093author name stringChristian Steinkühler
Gessica Filocamo
Mirko Brunetti
Paola Gallinari
Claudio Dello Russo
Emanuele de Rinaldis
Sabina Coppari
Silvia Fedeli
P2860cites workShugoshin collaborates with protein phosphatase 2A to protect cohesinQ24307927
The consensus coding sequences of human breast and colorectal cancersQ27861035
P433issue15
P407language of work or nameEnglishQ1860
P304page(s)6074-6082
P577publication date2009-07-21
P1433published inCancer ResearchQ326097
P1476titleLoss of histone deacetylase 4 causes segregation defects during mitosis of p53-deficient human tumor cells
P478volume69

Reverse relations

cites work (P2860)
Q37568629Class IIa HDACs: from important roles in differentiation to possible implications in tumourigenesis.
Q94471881Conditional deletion of HDAC4 from collagen type 2α1-expressing cells increases angiogenesis in vivo
Q91621948Dephosphorylation of HDAC4 by PP2A-Bδ unravels a new role for the HDAC4/MEF2 axis in myoblast fusion
Q47741808Estrogen, through estrogen receptor 1, regulates histone modifications and chromatin remodeling during spermatogenesis in adult rats
Q52148764HDAC4 stabilizes SIRT1 via sumoylation SIRT1 to delay cellular senescence.
Q30557593MEF2 is a converging hub for histone deacetylase 4 and phosphatidylinositol 3-kinase/Akt-induced transformation
Q24598698Nuclear export and centrosome targeting of the protein phosphatase 2A subunit B56alpha: role of B56alpha in nuclear export of the catalytic subunit
Q37062452Overexpressed HDAC4 is associated with poor survival and promotes tumor progression in esophageal carcinoma
Q47271622PP2A as the Main Node of Therapeutic Strategies and Resistance Reversal in Triple-Negative Breast Cancer.
Q30577179Salt-inducible kinase 3 is a novel mitotic regulator and a target for enhancing antimitotic therapeutic-mediated cell death
Q24618224Tasquinimod Is an Allosteric Modulator of HDAC4 survival signaling within the compromised cancer microenvironment
Q26770428Tasquinimod in the treatment of castrate-resistant prostate cancer - current status and future prospects
Q35476003Thailandepsins: bacterial products with potent histone deacetylase inhibitory activities and broad-spectrum antiproliferative activities.
Q26739246The broken "Off" switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillance
Q35744353The landscape and therapeutic relevance of cancer-associated transcript fusions.
Q41780478The multi zinc-finger protein Trps1 acts as a regulator of histone deacetylation during mitosis
Q38204386Towards selective inhibition of histone deacetylase isoforms: what has been achieved, where we are and what will be next
Q30497896Ubiquitin-dependent degradation of HDAC4, a new regulator of random cell motility.
Q57469278Unscheduled HDAC4 repressive activity in human fibroblasts triggers TP53-dependent senescence and favours cell transformation

Search more.